BioLine RX Ltd (NASDAQ:BLRX)

3.95
Delayed Data
As of 12:48pm ET
 -0.33 / -7.71%
Today’s Change
3.90
Today|||52-Week Range
27.60
-39.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization440.8K483.5K484.4K449.5K
 
 
 
 
 
 
Operating ExpensesGross Income-440.8K-483.5K-484.4K-449.5K
 
 
 
 
 
General Expenses15.7M16.1M24.9M25.1M
 
 
 
 
 
Research And Development11.1M10.8M19.2M19.3M
 
 
 
 
 
Total Operating Expenses16.2M16.6M25.4M25.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.2M-16.6M-25.4M-25.5M
 
 
 
 
 
Extraordinary Credit1.4M207.7K347.4K1.7M
 
 
 
 
 
Extraordinary Charge0.00---127.9K--
 
 
Interest Expense On Debt15.0K14.0K21.1K471.5K
 
 
 
 
 
Other Expenses-91.0K-1.0K-133.9K651.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.4M-15.9M-24.5M-22.9M
 
 
 
 
 
Net Income-14.4M-15.9M-24.5M-22.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.4M56.1M90.0M108.6M
 
 
 
 
 
Shares To Calculate EPS Diluted51.4M56.1M90.0M108.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.28-$0.27-$0.21
 
 
 
 
 
EPS Diluted-$0.28-$0.28-$0.27-$0.21